Colon Dialysis with Yishen Decoction Improves Autophagy Disorder in Intestinal Mucosal Epithelial Cells of Chronic Renal Failure by Regulating SIRT1 Pathway.
10.1007/s11655-025-3829-6
- Author:
Yan-Jun FAN
1
;
Jing-Ai FANG
1
;
Su-Fen LI
2
;
Ting LIU
1
;
Wen-Yuan LIU
1
;
Ya-Ling HU
1
;
Rui-Hua WANG
1
;
Hui LI
1
;
Da-Lin SUN
1
;
Guang ZHANG
1
;
Zi-Yuan ZHANG
3
,
4
Author Information
1. Department of Nephrology, the First Hospital of Shanxi Medical University, Taiyuan, 030001, China.
2. Department of Pathology, the First Hospital of Shanxi Medical University, Taiyuan, 030001, China.
3. Department of Nephrology, the First Hospital of Shanxi Medical University, Taiyuan, 030001, China. ziye_402@
4. com.
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
Yishen Decoction;
autophagy;
chronic renal failure;
colon dialysis;
intestinal mucosal barrier
- MeSH:
Animals;
Sirtuin 1/metabolism*;
Drugs, Chinese Herbal/therapeutic use*;
Autophagy/drug effects*;
Male;
Intestinal Mucosa/drug effects*;
Rats, Sprague-Dawley;
Epithelial Cells/metabolism*;
Colon/drug effects*;
Humans;
Kidney Failure, Chronic/drug therapy*;
Signal Transduction/drug effects*;
Renal Dialysis;
Rats;
Kidney/drug effects*
- From:
Chinese journal of integrative medicine
2025;31(10):899-907
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To explore the mechanism of colon dialysis with Yishen Decoction (YS) in improving the autophagy disorder of intestinal epithelial cells in chronic renal failure (CRF) in vivo and in vitro.
METHODS:Thirty male SD rats were randomly divided into normal, CRF, and colonic dialysis with YS groups by a random number table method (n=10). The CRF model was established by orally gavage of adenine 200 mg/(kg•d) for 4 weeks. CRF rats in the YS group were treated with colonic dialysis using YS 20 g/(kg•d) for 14 consecutive days. The serum creatinine (SCr) and urea nitrogen (BUN) levels were detected by enzyme-linked immunosorbent assay. Pathological changes of kidney and colon tissues were observed by hematoxylin and eosin staining. Autophagosome changes in colonic epithelial cells was observed with electron microscopy. In vitro experiments, human colon cancer epithelial cells (T84) were cultured and divided into normal, urea model (74U), YS colon dialysis, autophagy activator rapamycin (Ra), autophagy inhibitor 3-methyladenine (3-MA), and SIRT1 activator resveratrol (Re) groups. RT-PCR and Western blot were used to detect the mRNA and protein expressions of zonula occludens-1 (ZO-1), Claudin-1, silent information regulator sirtuin 1 (SIRT1), LC3, and Beclin-1 both in vitro and in vivo.
RESULTS:Colonic dialysis with YS decreased SCr and BUN levels in CRF rats (P<0.05), and alleviated the pathological changes of renal and colon tissues. Expressions of SIRT1, ZO-1, Claudin-1, Beclin-1, and LC3II/I were increased in the YS group compared with the CRF group in vivo (P<0.05). In in vitro study, compared with normal group, the expressions of SIRT1, ZO-1, and Claudin-1 were decreased, and expressions of Beclin-1, and LC3II/I were increased in the 74U group (P<0.05). Compared with the 74U group, expressions of SIRT1, ZO-1, and Claudin-1 were increased, whereas Beclin-1, and LC3II/I were decreased in the YS group (P<0.05). The treatment of 3-MA and rapamycin regulated autophagy and the expression of SIRT1. SIRT1 activator intervention up-regulated autophagy as well as the expressions of ZO-1 and Claudin-1 compared with the 74U group (P<0.05).
CONCLUSION:Colonic dialysis with YS could improve autophagy disorder and repair CRF intestinal mucosal barrier injury by regulating SIRT1 expression in intestinal epithelial cells.
